Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001 Dec;60(12):1103-9.
doi: 10.1136/ard.60.12.1103.

Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables

Affiliations
Comparative Study

Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables

I M Gilboe et al. Ann Rheum Dis. 2001 Dec.

Abstract

Objective: Firstly, to study the prevalence of ocular and oral sicca symptoms, reduced tear and saliva production, and the minimum frequency of secondary Sjögren's syndrome (sSS) in systemic lupus erythematosus (SLE). Secondly, to compare sicca symptoms and findings with those of matched patients with rheumatoid arthritis (RA), and sicca symptoms with those in healthy controls. Finally, to study possible associations of clinical variables with sicca symptoms and sSS in SLE.

Methods: Self reported sicca symptoms were recorded in 81 patients with SLE aged < or =70, 81 matched patients with RA, and 81 matched healthy controls. Other study variables included Schirmer-I test (S1T), unstimulated whole saliva, health status measures (in SLE and RA), disease activity, accumulated organ damage, and serological markers (in SLE).

Results: A significantly higher proportion of patients with SLE reported sicca symptoms than healthy controls. Further, a significantly higher proportion reported ocular sicca symptoms (43 and 21%, respectively) and had pathologically reduced S1T compared with RA (46 and 21%, respectively). No difference was seen in oral sicca symptoms and saliva production. In SLE, sicca symptoms were associated with fatigue, and sSS with anti-SSB or anti-SSA antibodies, or both.

Conclusions: An increased prevalence of sicca symptoms was found in patients with SLE compared with controls, and a higher prevalence of ocular sicca symptoms and reduced tear production in SLE compared with RA. Sicca problems should be considered in the care of patients with SLE, especially those with anti-SSB and/or anti-SSA antibodies who have sicca symptoms and fatigue.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proportions of matched patients with SLE and RA with one or more sicca symptoms, pathological reduced Schirmer-I test (S1T), and unstimulated whole saliva (UWS), keratoconjunctivitis sicca, xerostomia, and secondary Sjögren's syndrome (sSS). Keratoconjuntivitis sicca = one or more eye sicca symptoms in combination with pathological S1T; xerostomia = one or more mouth sicca symptoms in combination with pathological UWS. *p<0.05 SLE v RA (McNemar test).

References

    1. J Rheumatol. 1998 Jan;25(1):63-8 - PubMed
    1. Ann Rheum Dis. 1998 Jan;57(1):20-4 - PubMed
    1. J Rheumatol. 1998 Jun;25(6):1078-84 - PubMed
    1. Lupus. 1998;7(4):231-4 - PubMed
    1. J Rheumatol. 1999 Feb;26(2):504-7 - PubMed

Publication types